ASHP Midyear

Articles

In a live virtual symposium at the 2021 ASHP Midyear Clinical Meeting, 2 experts teamed up to highlight the place in therapy and management of oral oncolytics in follicular and marginal zone lymphoma.

Supporting Oral Oncolytics in Follicular and Marginal Zone Lymphomas

Videos

Teena Chopra, MD, MPH, professor of infectious diseases at Wayne State University, discussed how microbiome-based therapeutics may impact the current treatment landscape for C. diff infection and recurrent C. diff infection.

How Microbiome-based Therapeutics May Impact Treatment Landscape for C. Diff Infection, Recurrent C. Diff Infection

Teena Chopra, MD, MPH, professor of infectious diseases at Wayne State University, discussed the current burden of C. diff infection and recurrent C. diff infection.

Addressing the Current Burden of C. Diff Infection, Recurrent C. Diff Infection

Teena Chopra, MD, MPH, professor of infectious diseases at Wayne State University, addressed the risk factors for C. diff infection and recurrent C. diff infection.

Assessing the Risk Factors for C. Diff Infection, Recurrent C. Diff Infection

A panel recently re-convened recently to develop guidance for AmpC-bearing gram-negative pathogens.

Newest IDSA Guidance Pertains to AmpC-Bearing Gram-Negative Pathogens

The long-acting antiretroviral therapy is intended to replace antiretroviral regimens for individuals who are virologically suppressed.

Experts Review Cabotegravir, Rilpivirine Therapy for Treatment of HIV Infections

In this video, Dr. Sherman recommends strategies for solving drug therapy related problems common to long-acting antiretroviral agents, such as missed doses, adverse drug reactions and drug–drug interactions.

Strategies for Solving Drug Therapy Related Problems in HIV Prevention Drugs

Teena Chopra, MD, MPH, professor of infectious diseases at Wayne State University, addressed the relationship between gut microbiome and C. diff infection.

Relationship Between Gut Microbiome, C. Diff Infection

Teena Chopra, MD, MPH, professor of infectious diseases at Wayne State University, discusses the current treatment strategies for C. diff infection and recurrent C. diff infection, as well as the efficacy and safety of these treatments.

Efficacy, Safety of Current Treatments for C. Diff Infection, Recurrent C. Diff Infection

In an interview with Pharmacy Times, Thomas Lodise, PharmD, PhD, discussed new guidance released by the Infectious Diseases Society of America (IDSA) on the treatment of antimicrobial resistant gram-negative infections.